Yong-Mi Kim

5PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

|Aug 14, 2025
Targeting Wnt Signaling in Acute Lymphoblastic Leukemia.

Samantha Hurwitz, Ki Jun Lee, Tatiana Fourfouris

|Dec 03, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.

Samy Jambon, Jianping Sun, Shawn Barman

|Sep 10, 2021
Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.

Kaori Saito, Qi Zhang, Haeun Yang

|Nov 09, 2017
Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.

Yann Duchartre, Stefanie Bachl, Hye Na Kim

Pageof 1

Frequent Collaborators

1 joint publications

Kotoko Yamatani

1 joint publications

Tomohiko Ai

1 joint publications

Vivian Ruvolo

1 joint publications

Natalia Baran